Dr Peter G. Pappas is a Professor of Medicine in the Division of Infectious Diseases and Tinsley Harrison Clinical Scholar, Department of Medicine at the University of Alabama in Birmingham. Dr Pappas attended medical school at the University of Alabama at Birmingham, graduating in 1978. He completed his residency in internal medicine, chief medical residency, and infectious diseases fellowship at the University of Washington in Seattle.
Following completion of his fellowship, he was on the clinical faculty at the University of North Carolina School of Medicine in Chapel Hill, NC, through its affiliated hospital in Wilmington, North Carolina. In 1988, he joined the faculty at the University of Alabama in Birmingham School of Medicine, with a focus on HIV and transplant-associated opportunistic infections, especially the invasive mycoses.
His main areas of interest have included the development of new therapies for fungal infections and understanding the epidemiology of candidiasis, the endemic mycoses, and cryptococcosis. He has performed a number of clinical trials in candidiasis, cryptococcosis, aspergillosis, sporotrichosis, blastomycosis, and histoplasmosis through his involvement with the NIAID BAMSG.
He is the Principal Investigator for the Mycoses Study Group, a group that will continue to perform multicenter trials, create treatment guidelines for invasive mycoses, and coordinate CME training in the epidemiology, diagnosis and treatment of invasive mycoses. He is also the PI of a national network of transplant centers, TRANSNET, in conjunction with CDC and a consortium of industry co-sponsors to provide important epidemiologic and treatment information to transplant recipients who develop proven and probable invasive fungal infections. Finally, he is co-PI of the Organ Transplant Infection Detection and Prevention Program (OTIP), a collaborative multicenter group funded by CDC.
Dr Dimitrios P. Kontoyiannis received his medical degree Summa Cum Laude from the National and Kapodistrian University of Athens in Greece. He then completed a postdoctoral clinical research fellowship in Mycology at the Section of Infectious Diseases at the University of Texas MD Anderson Cancer Center in Houston, Texas, followed by training in Internal Medicine at Baylor College of Medicine in Houston, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School in Boston. He spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. He is currently the Director of the Mycology Research Program and Professor in the Department of Infectious Diseases Infection Control and Employee Health at the University of Texas MD Anderson Cancer Center. He is also an adjunct professor at the University of Houston College of Pharmacy. He serves as an associate editor for Medical Mycology and sits on the editorial boards of Antimicrobial Agents & Chemotherapy, Medical Mycology, and Transplant Infectious Disease. He is a reviewer in several peer-reviewed journals in infectious diseases, oncology, and hematology. Dr Kontoyiannis has authored more than 170 peer-reviewed manuscripts and over 30 invited articles and book chapters.
Dr Sanjay G. Revankar earned his bachelors degree at Northwestern University, then his medical degree at the University of Illinois at Chicago. He completed an internship and residency in internal medicine at the University of Michigan Hospitals, Ann Arbor, followed by an infectious diseases fellowship and a Pfizer mycology fellowship at the University of Texas Health Science Center at San Antonio. He is board certified in infectious disease and internal medicine and is a member of the Infectious Diseases Society of America and the American Society of Microbiology.
Results of Dr Revankar’s research into HIV infections and other infectious diseases have been presented at ICAAC, ASM, and IDSA meetings and published in such major journals as Mycoses, Clinical Infectious Diseases, Journal of Infectious Diseases, and Antimicrobial Agents and Chemotherapy. He has most recently focused on the applications for the azoles in treating fungal infections.
Dr George R. Thompson is Associate Professor of Medicine at the University of California, Davis, School of Medicine with a joint appointment in the Departments of Medical Microbiology and Immunology, and Internal Medicine, Division of Infectious Diseases. Dr Thompson specializes in the care of patients with invasive fungal infections and has research interest in fungal diagnostics, host immunogenetics, and translational mycology.
Dr Thompson is a Co-chair of the Mycoses Study Group Education Committee, which is responsible for the dissemination of materials and knowledge to clinicians across the country to improve the care of patients with fungal infections. He has also been appointed to the Coccidioidomycosis Study Group and the Infectious Diseases Society of America (IDSA) Journal Club, providing editorials in the monthly internationally disseminated IDSA Newsletter.
Dr Pappas is the William E. Dismukes Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at the University of Alabama at Birmingham. Dr Pappas attended medical school at the University of Alabama at Birmingham, graduating in 1978. He completed his residency in internal medicine, chief medical residency, and infectious diseases fellowship at the University of Washington in Seattle in 1983.
Following completion of his fellowship, he was on the clinical faculty at the University of North Carolina School of Medicine in Chapel Hill, through its affiliated hospital in Wilmington, North Carolina. In 1988, he joined the faculty at the University of Alabama at Birmingham School of Medicine, with a focus on HIV and transplant-associated opportunistic infections, especially the invasive mycoses. His main areas of interest have included the development of new therapies and diagnostics for fungal infections and understanding the epidemiology of candidiasis, the endemic mycoses, and cryptococcosis. Over the last 25 years, he has performed a number of clinical studies involving invasive candidiasis, cryptococcosis, aspergillosis, sporotrichosis, blastomycosis, and histoplasmosis through his involvement in the Mycoses Study Group.
He is currently the Principal Investigator for the Mycoses Study Group Education and Research Consortium (MSG ERC), a group that performs multicenter clinical trials, creates treatment guidelines for invasive mycoses, and coordinates CME training in the epidemiology, diagnosis, and treatment of invasive mycoses. He also served as the principal investigator of a national network of transplant centers, TRANSNET, in conjunction with the CDC and a consortium of industry co-sponsors to explore important epidemiologic and treatment information among transplant recipients who develop proven and probable invasive fungal infections. He was also co-PI of the Organ Transplant Infection Detection and Prevention Program (OTIP), a collaborative multicenter group funded by the CDC. Finally, Dr Pappas has served as director of the Antimicrobial Stewardship Program at UAB since its formation in 2008.
Professor Arendrup is Head of the Mycology Unit at Statens Serum Institut, Copenhagen, where she is responsible for the fungal laboratory, which receives 15,000 routine and reference samples per year for culture, susceptibility testing, antigen- and antibody-detection, and PCR as well as for the semi-national surveillance of invasive fungal infections. She is responsible for the supervision of several PhD students and holds a full professorship at the Århus University.
Professor Arendrup obtained her medical degree from Copenhagen University, Denmark, in 1988, followed by a PhD degree on neutralizing antibodies and HIV infection in 1992. In 2001, she completed further training as a specialist in clinical microbiology and in September 2013 her doctoral thesis on epidemiology and susceptibility of candidaemia was defended for the Dr. Med. Sci degree. Prof Arendrup was the founder of the Nordic Society of Medical Mycology (NSMM) and has been president since the formation of the society in 2003 until 2013. She is chair of the EUCAST Antifungal Susceptibility Testing Subcommittee Steering Committee, head of the EUCAST Development Laboratory for fungi, and an editor for Drug Resistance Updates. In 2005-2009 and 2011-13 she served as a European Confederation of Medical Mycology (ECMM) delegate on the executive organizing committee for TIMM-3 and 4 and as delegate for NSMM for the TIMM 6 in Copenhagen. She was on the international scientific committee for TIMM 7 in Lisbon, and has served as advisor for the CLSI committee for 4 years ending in 2014.
Professor Arendrup has authored more than 160 publications in international journals and book chapters. She has received two research awards (Fritz Kauffman’s award in 2003 and The Danish Society for Clinical Microbiology’s research award in 2010). Her main research interests include the epidemiology, susceptibility, breakpoint development, diagnostics, and treatment of fungal infections.
Doctor Dodds Ashley is currently a liaison pharmacist with the Duke Antimicrobial Stewardship Outreach Network (DASON) based at Duke University, Durham, North Carolina. She received her Doctor of Pharmacy degree from the Bouvé College of Pharmacy and Health Sciences at Northeastern University, Boston, Massachusetts. She subsequently completed her pharmacy practice residency at Duke University Health System and a specialty residency in adult internal medicine/infectious disease with Duke University Health System and Campbell University, Buies Creek, North Carolina, before joining the Department of Medicine at Duke University Medical Center. In 2006 she completed her Masters in Health Science in Clinical Research at Duke University School of Medicine.
While at Duke, she served as the clinical pharmacist for the Infectious Diseases Transplant Consult Service and Co-Chair of the Antibiotic Evaluation Team as well as a Clinical Assistant Professor of Pharmacy Practice at the Campbell University School of Pharmacy. She left Duke in 2008 and moved to the University of Rochester, where she served as the Associate Director for Clinical Pharmacy Services and an Infectious Diseases pharmacist until June 2015, when she accepted her current position. She is a board-certified pharmacotherapy specialist with added qualifications in infectious disease and a Fellow of the American College of Clinical Pharmacy. Her teaching, research, and patient care activities focus on appropriate use of anti-infective agents, antimicrobial stewardship, and infectious diseases in the transplant population. She has served as a member of the Antimicrobial Resistance Working Group at the Centers for Disease Control and Prevention and an expert panel member of the Transatlantic Taskforce for Antimicrobial Resistance, among other appointments. She was the recipient of a Society of Infectious Diseases Pharmacists Research Award (2006-2007) and has served the society as a member of the Strategic Planning Committee (2007-2008) and the Board of Directors (2010-2012). She was also Chair of the Infectious Diseases Practice and Research Network of the American College of Clinical Pharmacy, and a former board member of the Society of Infectious Diseases Pharmacists.
Dr Patterson is Professor and Chief of Medicine in the Division of Infectious Diseases at the University of Texas Health Science Center in San Antonio, Texas, where he is also the Director of the San Antonio Center for Medical Mycology and Director for the Infectious Diseases Fellowship program.
Dr. Patterson received his Bachelor of Arts degree from Baylor University followed by his medical degree from the University of Texas. Subsequently, he completed a medicine residency at Vanderbilt University and Yale-New Haven Hospital. He was then a postdoctoral fellow in infectious diseases at Yale University School of Medicine.
Dr. Patterson is a member of numerous professional committees and societies, including the Infectious Diseases Society of America, American Society for Microbiology, and International Society for Human and Animal Mycoses. He serves as a reviewer for several professional journals such as the Journal of Clinical Microbiology and Annals of Internal Medicine. In addition, he currently holds several editorial positions, including being Co-Editor-in-Chief of www.doctorfungus.org. His research has appeared in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology, and Antimicrobial Agents and Chemotherapy. He has been published in print and audio formats and has been invited across the globe to speak as a guest lecturer.